Decay-accelerating factor mitigates controlled hemorrhage-instigated intestinal and lung tissue damage and hyperkalemia in swine

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue SUPPL. 1, 2011, Pages

  Lucca, Jurandir J Dalle ^a   Simovic, Milomir ^a   Li, Yansong ^a   Moratz, Chantal ^b   Falabella, Michael ^a   Tsokos, George C ^c  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement system; Decay accelerating factor; Hemorrhage; Ischemia; Resuscitation

Indexed keywords

DECAY ACCELERATING FACTOR; RECOMBINANT ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CLINICAL EVALUATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; FAR WESTERN BLOTTING; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; HYPERKALEMIA; HYPOTENSION; IMMUNOHISTOCHEMISTRY; LUNG INJURY; LUNG PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RURAL AREA; SMALL INTESTINE; TISSUE INJURY;

ANIMALS; ANTIGENS, CD55; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; HEMODYNAMICS; HUMANS; HYPERKALEMIA; INTESTINES; LUNG; MALE; RECOMBINANT PROTEINS; RESUSCITATION; SHOCK, HEMORRHAGIC; SWINE; TIME FACTORS;

EID: 79960403281     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318221aa4c     Document Type: Article

References (24)

1. Martin M, Oh J, Currier H, Tai N, et al. An analysis of in-hospital deaths at a modern combat support hospital. J Trauma. 2009;66:S51-S60.
2. Yao YM, Redl H, Bahrami S, Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998;47: 201-210. (Pubitemid 28256968)
3. Shoemaker WC, Appel P, Czer LS, Bland R, Schwartz S, Hopkins JA. Pathogenesis of respiratory failure (ARDS) after hemorrhage and trauma: I. Cardiorespiratory patterns preceding the development of ARDS. Crit Care Med. 1980;8:504-512.
4. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res. 2006;12:151-170. (Pubitemid 47487521)
5. Wenzel V, Raab H, Dunser MW. Arginine vasopressin: a promising rescue drug in the treatment of uncontrolled haemorrhagic shock. Best Pract Res Clin Anaesthesiol. 2008;22:299-316. (Pubitemid 351804044)
6. Lu X, Li Y, Simovic MO, et al. Decay-accelerating factor attenuates C-reactive protein-potentiated tissue injury after mesenteric ischemia/reperfusion. J Surg Res. 2011;167:e103-e115.
7. Fleming SD, Phillips LM, Lambris JD, et al. Complement component C5a mediates hemorrhage-induced intestinal damage. J Surg Res. 2008; 150:196-203.
8. Li K, Sacks SH, Zhou W. The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol. 2007;44:3866-3874. (Pubitemid 47332623)
9. Ganter MT, Brohi K, Cohen MJ, et al. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28:29-34. (Pubitemid 46956459)
10. Tsukamoto T, Chanthaphavong RS, Pape HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury. 2010;41:21-26.
11. Pope A, French G, Longnecker DE, eds. Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries. Washington, DC: National Academy Press; 1999: 1-8, 47-78, 97-108.
12. Dubick MA, Atkins JL. Small-volume fluid resuscitation for the far-forward combat environment: current concepts. J Trauma. 2003;54:S43-S45. (Pubitemid 36758850)
13. Weeks C, Moratz C, Zacharia A, et al. Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage. Clin Immunol. 2007;124:311-327. (Pubitemid 47247607)
14. Peckham RM, Handrigan MT, Bentley TB, et al. C5-blocking antibody reduces fluid requirements and improves responsiveness to fluid infusion in hemorrhagic shock managed with hypotensive resuscitation. J Appl Physiol. 2007;102:673-680. (Pubitemid 46220898)
15. Pfeifer R, Tarkin IS, Rocos B, Pape HC. Patterns of mortality and causes of death in polytrauma patients-Has anything changed? Injury. 2009;40: 907-911.
16. Szebeni J, Baranyi L, Savay S, et al. Complement activation during hemorrhagic shock and resuscitation in swine. Shock. 2003;20:347-355.
17. Wang Y, Li Y, Dalle Lucca SL, et al. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury. J Neuroinflammation. 2010;7:24-36.
18. Hecke F, Schmidt U, Kola A, Bautsch W, Klos A, Kohl J. Circulating complement proteins in multiple trauma patients- correlation with injury severity, development of sepsis, and outcome. Crit Care Med. 1997;25: 2015-2024. (Pubitemid 28007240)
19. Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology and function. Annu Immunol. 1989;7:35-38.
20. Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW, Shaw AS, Lublin DM. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinase p56lck and p59fyn 1. J immunol. 1992;149:3535-3541.
21. Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci. 2004;5:317-328. (Pubitemid 38478658)
22. Okamoto K, Wang W, Rounds J, Chambers E, Jacobs DO. Sublytic complement attack increases intracellular sodium in rat skeletal muscle. J Surg Res. 2000;90:174-182. (Pubitemid 30314457)
23. Xie Z, Cai T. Na-K-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv. 2003;3:157-168.
24. Zhang X, Kimura Y, Fang C, et al. Regulation of Toll-like receptormediated inflammatory response by complement in vivo. Blood. 2007; 110:228-236. (Pubitemid 47026839)